Mallory Farrar provides healthcare regulatory counsel as it relates to compliance, operational and transactional matters.
Mallory earned her law degree from the University of Memphis Cecil C. Humphreys School of Law and a B.A. in political science from the University of North Carolina at Asheville.
American Health Law Association (AHLA)
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Representation of American Physician Partners (APP), a leader in emergency medicine, hospitalist and intensivist management services, in its acquisition of TruePartners Emergency Physicians, an emergency medicine group based in Wellington, Florida
Representation of Clearway Pain Solutions, an interventional pain management medical practice that is backed by NexPhase, in its merger with KureSmart Pain Management
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
We represented HealthTrust (Healthtrust Purchasing Group, L.P.) in its definitive agreement to acquire Resource Optimization & Innovation (ROi), a recognized leader in healthcare supply chain management.
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented Community Pharmacy Partners in its investment by Altaris Capital Partners, LLC.
University of Memphis Law Review — Sr. Editorial Board, Research Editor
Dean’s Award for Excellence — Best Oral Advocate; Best Memo
CALI Excellence for the Future Award — Torts; Business Organizations; Contract Drafting